Who owns the POLYGENRX trademark?

The POLYGENRX trademark is owned by PolygenRx Pty Ltd.

What class is the POLYGENRX trademark registered in?

The POLYGENRX trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for POLYGENRX?

The USPTO serial number for POLYGENRX is 79389137.

What is the registration number for POLYGENRX?

POLYGENRX is registered under USPTO registration number 7646725.

Sealvo

Home Search: POLYGENRXPOLYGENRX #79389137

Back

Updated Sep 28, 2026·18 searches this week

View on USPTO TSDR Find similar marks

POL

USPTO Trademark Record

REGISTERED

POLYGENRX

SN 79389137·Reg 7646725·Filed Jan 02, 2024

Owner PolygenRx Pty Ltd

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

POLYGENRX (Serial No. 79389137), Registration No. 7646725, is a registered US trademark filed on Jan 02, 2024 by PolygenRx Pty Ltd. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: January 14, 2031

Conflict Analysis

Full conflict analysis for POLYGENRX (SN 79389137) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

POLYGENRX (Reg. #7646725) is a registered US trademark that has been protecting its owner, PolygenRx Pty Ltd, since 2024. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 4 opposition proceedings during prosecution.

FILED

Jan 02, 2024

SERIAL

79389137

REG#

7646725

REGISTERED

Jan 14, 2025

Filing Information

StatusREGISTERED

Filing DateJan 02, 2024

Serial Number79389137

Registration No.7646725

Registration DateJan 14, 2025

Status DateJan 14, 2025

Published for OppositionNov 26, 2024

Filing Basis & Declarations

Standard Characters Claimed

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

29 events

FINAL DECISION TRANSACTION PROCESSED BY IB

Aug 15, 2025

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION NOTICE SENT TO IB

Jul 30, 2025

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION PROCESSED

Jul 29, 2025

FINAL DISPOSITION PROCESSED

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Jul 26, 2025

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Jul 07, 2025

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Jul 07, 2025

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Apr 15, 2025

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Jan 14, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jan 14, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Nov 26, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 26, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 20, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 01, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Oct 31, 2024

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Oct 31, 2024

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Oct 31, 2024

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Oct 31, 2024

EXAMINER'S AMENDMENT ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 11, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 11, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 11, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Sep 08, 2024

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Aug 16, 2024

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Aug 16, 2024

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Aug 08, 2024

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Aug 07, 2024

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Jul 30, 2024

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Feb 16, 2024

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 12, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Feb 10, 2024

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by PolygenRx Pty Ltd

Additional USPTO filings from the same owner.

PHA

PHARMAGENIC ENRICHMENT

79389202

PolygenRx Pty Ltd

REGISTERED

Other Marks by Fatima Y. Kassem

Additional USPTO filings handled by the same attorney of record.

HEI

HEIR LOOM

98852996

REGISTERED

AUD

AUDIT PRO

99402349

REGISTERED

BRI

BRICK SLAYERZ

99523419

REGISTERED

FOR

FORT HILL DISTRIBUTORS

98417836

REGISTERED

POLYGENRX

Run a conflict check

Other Marks by PolygenRx Pty Ltd

Other Marks by Fatima Y. Kassem

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company